News | Heart Valve Technology | July 20, 2016

Twisting of the Heart May Predict Mitral Valve Surgery Outcomes

Procedure may only be appropriate for certain patients

mitral valve surgery outcomes, twisting of the heart, echocardiography, NICSMR, JACC Basic to Translational Science

July 20, 2016 — A novel study has found a simple pre-operative echocardiographic measurement of the amount of torsion of the heart predicted outcomes of mitral valve surgery in some heart failure patients. The study was published in JACC: Basic to Translational Science.

The selection of appropriate candidates for mitral surgery among symptomatic patients with nonischemic, chronic secondary severe mitral regurgitation (NICSMR) can be challenging. This study demonstrates that assessment of left ventricular torsion — a twisting motion — may be useful for the prediction of post-mitral surgery outcomes in some patients.

Researchers examined 50 consecutive symptomatic NICSMR patients for a median follow-up of 2.5 years after mitral surgery. All patients had advanced heart failure symptoms and had already received the maximum guideline-directed medical therapy for more than six months. Baseline left ventricular size, shape and mass tended to be larger and more spherical in those who died, but not significantly so, while left ventricular torsion was higher in survivors. Patients were divided into three groups: preserved left ventricular torsion, lost left ventricular torsion, or patients with a wide QRS measurement who received cardiac resynchronization therapy. 

Patients received either mitral valve repair or mitral valve replacement. Two years after surgery, 19 patients had died. Researchers determined that in patients with NICSMR and a narrow QRS width, preserved left ventricular torsion may be a better predictor of post-mitral surgery survival, while conversely, lost left ventricular torsion may lead to a poor post-surgical outcome. The post-surgical survival results were intermediate in patients with a wide QRS. Patients who received cardiac resynchronization therapy prior to mitral surgery showed significantly worse two-year survival than those who received the procedure during mitral surgery. However, the two groups had similar left ventricular torsion.

“These findings show that lost left ventricular torsion and previously administered cardiac resynchronization therapy appear to be markers of poor survival after mitral surgery in patients with NICSMR,” said Yuichi Notomi, M.D., from the division of cardiovascular imaging, department of cardiology at The Hayama Heart Center in Kanagawa, Japan, and the lead author of the study. “We also found that reverse remodeling was only observed in patients with preserved left ventricular torsion, demonstrating that lost left ventricular torsion and wide QRS were markers of no reverse remodeling viability.” 

This study demonstrates that for patients with left-ventricular torsion and a narrow QRS measurement, mitral surgery is an acceptable option and that left ventricular torsion can help to predict post-mitral surgery outcomes in patients with a narrow QRS but not in those with a wide QRS.

“Mechanistically, this study suggests that the loss of torsion in patients with heart failure may reflect irreversible structural damage to the heart which would prevent the heart from recovering after corrective surgery,” said Douglas L. Mann, M.D., FACC, editor-in-chief of JACC: Basic to Translational Science. “If correct, this will have much broader implications than improvement after mitral valve surgery since it may predict which patients with heart failure may get better on medications.” 

Mann added that these findings will need confirmation as the analysis was retrospective and took place in a small number of patients. 

For more information: www.basictranslational.onlinejacc.org


Related Content

News | Cardiovascular Ultrasound

April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound ...

Home April 05, 2024
Home
News | Cardiovascular Ultrasound

August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ...

Home August 24, 2023
Home
News | Cardiovascular Ultrasound

July 27, 2023 —UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial ...

Home July 27, 2023
Home
Feature | Cardiovascular Ultrasound

February 10, 2023 — GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement ...

Home February 10, 2023
Home
Feature | Cardiovascular Ultrasound | By Paul M Bojarski

Sudden cardiac arrest is a complex and challenging medical emergency because it can occur anywhere at any time and is ...

Home August 23, 2022
Home
News | Cardiovascular Ultrasound

August 9, 2022 — Butterfly Medical, an Israeli medical device company developing a novel minimally invasive solution to ...

Home August 09, 2022
Home
News | Cardiovascular Ultrasound

July 20, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced the first patient ...

Home July 20, 2022
Home
Sponsored Content | Videos | Cardiovascular Ultrasound

Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it ...

Home July 20, 2022
Home
Sponsored Content | Videos | Cardiovascular Ultrasound

Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to ...

Home July 07, 2022
Home
News | Cardiovascular Ultrasound

June 15, 2022 — Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft, a revolutionary non ...

Home June 15, 2022
Home
Subscribe Now